Delivery Order SPE2DB24D2205-SPE2DB25FEHYH
Award Date 9/23/25
Potential Completion Date 10/15/25
Potential Value $103K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Takhzyro 300 mg/2 ml syringes with a ceiling value of $34,342.56. This firm fixed-price delivery order is scheduled for completion by September 15, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract was awarded on a competitive basis with no set-aside designation. This delivery order operates under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $34,342.56 delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Takhzyro 300 mg/2 ml syringes. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award through open competition. Performance is scheduled for completion by August 6, 2025, and will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TAKHZYRO 300 MG/2 ML SYRINGE 2ML. The contract is a delivery order with a firm fixed price of $48,673.20 and an ultimate completion date of August 29, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $32,448.80 to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The contract is for the provision of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product, with a completion date of March 18, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at...
- This federal contract award was made by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to AmerisourceBergen Drug Corporation's Corporate Office division. The $32,448.80 firm-fixed-price delivery order is for the supply of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with an ultimate completion date of June 24, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- Amerisourcebergen Drug Corporation, operating as a division of Amerisourcebergen Corporation, has been awarded a $31,755.04 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to provide TAKHZYRO 300 MG/2 ML syringes. Performance will take place in Conshohocken, Pennsylvania over a period spanning from June 28, 2023 through July 20, 2023. The Defense Logistics Agency Troop Support Medical, which supports the medical supply needs of the U.S. Department...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Actemra 162 mg/0.9 ml syringes valued at $7,762.59 with firm fixed pricing. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's existing contract vehicle with the DLA. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Taltz 80 mg/ml auto-injector medication, with a ceiling value of $1,660.30. This firm fixed-price delivery order, which is scheduled for completion by August 11, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement. The award was made without a set-aside designation, indicating competitive award...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,060.43 to AmerisourceBergen Drug Corp for the supply of TADLIQ 20 mg/5 ml suspension in 150ml quantities. This firm fixed-price, non-set-aside delivery order was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,374.36 to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of TEZSPIRE 210 mg/1.91 mL auto-injector pens. This firm fixed-price delivery order, which is not associated with any set-aside program, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. The award represents a routine pharmaceutical procurement under the...